Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-02-001801
Filing Date
2002-09-26
Accepted
2002-09-26 16:41:56
Documents
9
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d52002_10-k.txt 10-K 285577
4 CERTIFICATE OF INCORPORATION AS AMENDED d52002_ex3i.txt EX-3.(I) 180897
5 2001 INCENTIVE STOCK PLAN d52002_ex10-14.txt EX-10.14 43144
6 DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT d52002_ex10-15.txt EX-10.15 158719
7 RATIO OF EARNINGS TO FIXED CHARGES d52002_ex12-1.txt EX-12.1 2276
8 SUBSIDIARIES OF REGISTRANT d52002_ex21-0.txt EX-21.0 591
9 INDEPENDENT AUDITOR'S CONSENT d52002_ex23-0.txt EX-23.0 1040
10 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d52002_ex99-1.txt EX-99.1 1420
11 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d52002_ex99-2.txt EX-99.2 1407
  Complete submission text file 0001169232-02-001801.txt   677714
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 02773412
SIC: 2836 Biological Products, (No Diagnostic Substances)